SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-206894
Filing Date
2023-08-09
Accepted
2023-08-09 09:26:58
Documents
14
Period of Report
2023-08-09
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d502246d8k.htm   iXBRL 8-K 47342
2 EX-3.1 d502246dex31.htm EX-3.1 7083
3 EX-3.2 d502246dex32.htm EX-3.2 79663
  Complete submission text file 0001193125-23-206894.txt   295681

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dice-20230809.xsd EX-101.SCH 2877
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dice-20230809_lab.xml EX-101.LAB 19482
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dice-20230809_pre.xml EX-101.PRE 12171
8 EXTRACTED XBRL INSTANCE DOCUMENT d502246d8k_htm.xml XML 3687
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: 8-K | Act: 34 | File No.: 001-40794 | Film No.: 231153638
SIC: 2834 Pharmaceutical Preparations